A new era in tuberculosis care has begun with the introduction of a highly affordable molecular test, priced at just $2.60.
A new era in tuberculosis care has begun with the introduction of a highly affordable molecular test, priced at just $2.60.
Opinion
allAfrica.com on MSNOpinion
SA Is One Step Closer to a New TB Vaccine, but There Is a Lot of Work Ahead
In March 2024, a pivotal clinical trial was launched to evaluate what might well become the first new tuberculosis vaccine on the market in more than a century. As anticipation mounts for the trial to ...
But when TB gets in, it’s in, and over the course of 10 months, it took absolutely everything. It started on Tuesday, 28 ...
The co-founder of the London-based note-taking app talks about how artificial intelligence is percolating through the ...
Doctors in Navi Mumbai have successfully treated a 47-year-old woman suffering from pulmonary tuberculosis and acute kidney ...
Nvidia Corporation is rated Strong Buy, driven by unmatched efficiency in AI hardware and robust earnings growth. Click for ...
In an independent benchmark conducted by Artificial Analysis, Nvidia’s LPX rack systems managed to churn out 3,400 tokens a ...
Speaking exclusively to Yorkshire Live, Peter described the full circle moment of opening the memorial garden at the World of ...
1dOpinion
There's good news on the clinical trial front; pathway to carry out early-stage trials is widening
Strengthening domestic trial capacity isn't just about closing a gap with global peers. It's about making sure India keeps a ...
Jabs against shingles, MMR, TB and cervical cancer have turned out to have some unexpected but welcome impacts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results